{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:46:03Z","timestamp":1778625963179,"version":"3.51.4"},"reference-count":81,"publisher":"Portland Press Ltd.","issue":"12","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"abstract":"<jats:p>The uroguanylin system is a newly discovered endocrine\/paracrine system that may have a role in the regulation of salt balance, appetite and gut health. The precursor pro-uroguanylin is predominantly synthesized in the gut, although there may be other sites of synthesis, including the kidney tubules. Products from pro-uroguanylin may mediate natriuresis following oral consumption of a salt load through both GC-C (guanylate cyclase C)-dependent and -independent mechanisms, and recent evidence suggests a role in appetite regulation. Local paracrine effects in the gut through GC-C stimulation may have tumour-suppressing actions through the regulation of cell proliferation and metabolism. Although most information on this system has been derived from knockout models, recent human studies have indicated possible roles in heart failure and renal failure. An improved understanding of the nature of its natriuretic, appetite and tumour-suppressing actions may facilitate the discovery of new therapies for heart failure, obesity and cancer prophylaxis.<\/jats:p>","DOI":"10.1042\/cs20120021","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T07:03:07Z","timestamp":1344582187000},"page":"659-668","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The uroguanylin system and human disease"],"prefix":"10.1042","volume":"123","author":[{"given":"Hazim","family":"Rahbi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafid","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald\u00a0J. L.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leong\u00a0L.","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, U.K."},{"name":"Leicester National Institute for Health Research Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"2021113010212571900_B1","first-page":"304","article-title":"Practical implications of current natriuretic peptide research","volume":"1","author":"Sagnella","year":"2000","journal-title":"JRAAS"},{"key":"2021113010212571900_B2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","article-title":"Evidence of the atrial location of receptors influencing urine flow","volume":"4","author":"Henry","year":"1956","journal-title":"Circ. Res."},{"key":"2021113010212571900_B3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.2932797","article-title":"Atrial natriuretic factor: a hormone produced by the heart","volume":"30","author":"de Bold","year":"1985","journal-title":"Science"},{"key":"2021113010212571900_B4","first-page":"437","article-title":"A comparison of natriuresis after oral and intravenous sodium loading in sodium depleted man: evidence for a gastrointestinal or portal monitor of sodium intake","volume":"49","author":"Lennane","year":"1975","journal-title":"Clin. Sci. Mol. Med."},{"key":"2021113010212571900_B5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.peptides.2004.08.031","article-title":"Cardiac and intestinal natriuretic peptides: insights from genetically modified mice","volume":"26","author":"Kuhn","year":"2005","journal-title":"Peptides"},{"key":"2021113010212571900_B6","first-page":"F342","article-title":"Characterization of human uroguanylin: a member of the guanylin peptide family","volume":"266","author":"Kita","year":"1994","journal-title":"Am. J. Physiol."},{"key":"2021113010212571900_B7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0092-8674(90)90497-3","article-title":"Guanylyl cyclase is a heat-stable enterotoxin receptor","volume":"63","author":"Schulz","year":"1990","journal-title":"Cell"},{"key":"2021113010212571900_B8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.2005080818","article-title":"Cellular effects of guanylin and uroguanylin","volume":"17","author":"Sindic","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010212571900_B9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1073\/pnas.89.3.947","article-title":"Guanylin: an endogenous activator of intestinal guanylate cyclase","volume":"89","author":"Currie","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010212571900_B10","doi-asserted-by":"crossref","first-page":"16019","DOI":"10.1016\/S0021-9258(18)41955-2","article-title":"Cloning and expression of guanylin: its existence in various mammalian tissues","volume":"267","author":"Schulz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2021113010212571900_B11","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1210\/endo.141.9.7644","article-title":"Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine","volume":"141","author":"Qian","year":"2000","journal-title":"Endocrinology"},{"key":"2021113010212571900_B12","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.90.22.10464","article-title":"Uroguanylin structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase","volume":"90","author":"Hamra","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010212571900_B13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/endo.137.1.8536621","article-title":"Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases","volume":"137","author":"Hamra","year":"1996","journal-title":"Endocrinology"},{"key":"2021113010212571900_B14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1210\/endo.140.4.6630","article-title":"Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family","volume":"140","author":"Forte","year":"1999","journal-title":"Endocrinology"},{"key":"2021113010212571900_B15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1590\/S0100-879X1999001100003","article-title":"Renal effects of uroguanylin and guanylin in\u00a0vivo","volume":"32","author":"Carrithers","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"2021113010212571900_B16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ki.1997.424","article-title":"Urine and plasma levels of uroguanylin and its molecular forms in renal diseases","volume":"52","author":"Kinoshita","year":"1997","journal-title":"Kidney Int."},{"key":"2021113010212571900_B17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(02)00069-1","article-title":"Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine","volume":"107","author":"Carrithers","year":"2002","journal-title":"Regul. Pept."},{"key":"2021113010212571900_B18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0092-8674(90)90497-3","article-title":"Guanylyl cyclase is a heat-stable enterotoxin receptor","volume":"63","author":"Schulz","year":"1990","journal-title":"Cell"},{"key":"2021113010212571900_B19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/338078a0","article-title":"A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor","volume":"338","author":"Chinkers","year":"1989","journal-title":"Nature"},{"key":"2021113010212571900_B20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/j.1460-2075.1994.tb06355.x","article-title":"Activation of intestinal CFTR Cl\u2212 channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase","volume":"13","author":"Chao","year":"1994","journal-title":"EMBO J."},{"key":"2021113010212571900_B21","doi-asserted-by":"crossref","first-page":"C607","DOI":"10.1152\/ajpcell.1992.263.3.C607","article-title":"Stimulation of intestinal Cl\u2212 transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP","volume":"263","author":"Forte","year":"1992","journal-title":"Am. J. Physiol."},{"key":"2021113010212571900_B22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/gast.1997.v112.pm9024297","article-title":"Guanosine 3,5-cyclic monophosphate-dependent protein kinase ii mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine","volume":"112","author":"Vaandrager","year":"1997","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B23","doi-asserted-by":"crossref","first-page":"26626","DOI":"10.1074\/jbc.270.44.26626","article-title":"Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMP-dependent protein kinase II","volume":"270","author":"French","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021113010212571900_B24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0016-5085(00)70419-7","article-title":"Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon","volume":"118","author":"Vaandrager","year":"2000","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0167-4781(99)00110-4","article-title":"Cloning of ClC-2 chloride channel from murine duodenum and its presence in CFTR knockout mice","volume":"1446","author":"Joo","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010212571900_B26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1159\/000335767","article-title":"Uroguanylin regulates net fluid secretion via the NHE2 isoform of the Na\/H+ exchanger in an intestinal cellular model","volume":"28","author":"Toriano","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"2021113010212571900_B27","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1073\/pnas.94.6.2705","article-title":"Regulation of intestinal uroguanylin\/guanylin receptor-mediated responses by mucosal acidity","volume":"94","author":"Hamra","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010212571900_B28","first-page":"G708","article-title":"Opossum colonic mucosa contains and guanylin peptides uroguanylin","volume":"270","author":"Hamra","year":"1996","journal-title":"Am. J. Physiol."},{"key":"2021113010212571900_B29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0016-5085(97)70198-7","article-title":"Uroguanylin is expressed by enterochromaffin cells in the rat gastrointestinal tract","volume":"113","author":"Perkins","year":"1997","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B30","doi-asserted-by":"crossref","first-page":"F1433","DOI":"10.1152\/ajprenal.00281.2010","article-title":"Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat","volume":"299","author":"Moss","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010212571900_B31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1172\/JCI200318743","article-title":"Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load","volume":"112","author":"Lorenz","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2021113010212571900_B32","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1210\/en.2007-1724","article-title":"Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules","volume":"149","author":"Qian","year":"2008","journal-title":"Endocrinology"},{"key":"2021113010212571900_B33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pharmthera.2004.08.007","article-title":"Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics","volume":"104","author":"Forte","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"2021113010212571900_B34","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1210\/en.2007-1725","article-title":"Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide","volume":"149","author":"Moss","year":"2008","journal-title":"Endocrinology"},{"key":"2021113010212571900_B35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000063311","article-title":"Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats","volume":"92","author":"Fukae","year":"2002","journal-title":"Nephron"},{"key":"2021113010212571900_B36","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1097\/01.mpg.0000228092.36089.7c","article-title":"The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response","volume":"43","author":"Elitsur","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2021113010212571900_B37","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1210\/endo.139.12.6347","article-title":"Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin","volume":"139","author":"Nakazato","year":"1998","journal-title":"Endocrinology"},{"key":"2021113010212571900_B38","doi-asserted-by":"crossref","first-page":"F561","DOI":"10.1152\/ajprenal.00282.2010","article-title":"The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor)","volume":"300","author":"Qian","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010212571900_B39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/bbrc.1996.0255","article-title":"Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma","volume":"219","author":"Fan","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010212571900_B40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(96)02103-9","article-title":"Purification, cDNA sequence, and tissue distribution of rat uroguanylin","volume":"68","author":"Li","year":"1997","journal-title":"Regul. Pept."},{"key":"2021113010212571900_B41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.1990.76","article-title":"Effects of atrial natriuretic peptide on distal tubule function in humans","volume":"37","author":"Rabelink","year":"1990","journal-title":"Kidney Int."},{"key":"2021113010212571900_B42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1523-1755.2004.00375.x","article-title":"Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor","volume":"65","author":"Carrithers","year":"2004","journal-title":"Kidney Int."},{"key":"2021113010212571900_B43","first-page":"F882","article-title":"Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides","volume":"276","author":"London","year":"1999","journal-title":"Am. J. Physiol."},{"key":"2021113010212571900_B44"},{"key":"2021113010212571900_B45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/HYPERTENSIONAHA.108.128264","article-title":"The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers","volume":"53","author":"Moss","year":"2009","journal-title":"Hypertension"},{"key":"2021113010212571900_B46","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.1074\/jbc.M110627200","article-title":"Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and\/or a pertussis toxin-sensitive G protein in human proximal tubule cells","volume":"277","author":"Sindi\u0107e","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021113010212571900_B47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1523-1755.2005.00518.x","article-title":"Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C","volume":"68","author":"Sindi\u0107","year":"2005","journal-title":"Kidney Int."},{"key":"2021113010212571900_B48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0008-6363(00)00297-2","article-title":"Cellular localization, membrane distribution, and possible function of guanylyl cyclases A and 1\u00a0in collecting ducts of rat","volume":"51","author":"Hirsch","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"2021113010212571900_B49","doi-asserted-by":"crossref","first-page":"F614","DOI":"10.1152\/ajprenal.00189.2011","article-title":"The pendrin anion exchanger gene is transcriptionally regulated by uroguanylin: a novel enterorenal link","volume":"302","author":"Rozenfeld","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010212571900_B50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000335100","article-title":"Transcriptional regulation of the pendrin gene","volume":"28","author":"Rozenfeld","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"2021113010212571900_B51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.regpep.2009.07.011","article-title":"High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion","volume":"158","author":"Fonteles","year":"2009","journal-title":"Regul. Pept."},{"key":"2021113010212571900_B52","first-page":"E957","article-title":"Structure and activity of uroguanylin and guanylin from the intestine and urine of rats","volume":"273","author":"Fan","year":"1997","journal-title":"Am. J. Physiol."},{"key":"2021113010212571900_B53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0014-5793(95)01075-P","article-title":"GCAP-II: isolation and characterization of the circulating form of human uroguanylin","volume":"374","author":"Hess","year":"1995","journal-title":"FEBS Lett."},{"key":"2021113010212571900_B54","doi-asserted-by":"crossref","first-page":"H538","DOI":"10.1152\/ajpheart.2000.278.2.H538","article-title":"Increased urinary excretion of uroguanylin in patients with congestive heart failure","volume":"278","author":"Carrithers","year":"2000","journal-title":"Am. J. Physiol. Heart Circ Physiol."},{"key":"2021113010212571900_B55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20090338","article-title":"Activation of a novel natriuretic endocrine system in humans with heart failure","volume":"118","author":"Narayan","year":"2010","journal-title":"Clin. Sci."},{"key":"2021113010212571900_B56","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/hrt.2009.170696","article-title":"Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath","volume":"95","author":"Dieplinger","year":"2009","journal-title":"Heart"},{"key":"2021113010212571900_B57","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/toxins2082028","article-title":"Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics","volume":"2","author":"Lin","year":"2010","journal-title":"Toxins"},{"key":"2021113010212571900_B58","first-page":"3124","article-title":"Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays","volume":"61","author":"Notterman","year":"2001","journal-title":"Cancer Res."},{"key":"2021113010212571900_B59","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.276.5316.1268","article-title":"Gene expression profiles in normal and cancer cells","volume":"276","author":"Zhang","year":"1997","journal-title":"Science"},{"key":"2021113010212571900_B60","first-page":"4352","article-title":"Gene expression in colorectal cancer","volume":"62","author":"Birkenkamp-Demtroder","year":"2002","journal-title":"Cancer Res."},{"key":"2021113010212571900_B61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/bbrc.2000.2917","article-title":"Expression of guanylin is downregulated in mouse and human intestinal adenomas","volume":"273","author":"Steinbrecher","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010212571900_B62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2009.08.064","article-title":"The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling","volume":"138","author":"Lin","year":"2010","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.gastro.2007.05.052","article-title":"Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity","volume":"133","author":"Li","year":"2007","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B64","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0002-9440(10)64494-X","article-title":"Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation","volume":"161","author":"Steinbrecher","year":"2002","journal-title":"Am. J. Pathol."},{"key":"2021113010212571900_B65","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2353\/ajpath.2007.070198","article-title":"Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine","volume":"171","author":"Li","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2021113010212571900_B66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1752-8062.2008.00040.x","article-title":"Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy","volume":"1","author":"Li","year":"2008","journal-title":"Clin. Transl. Sci."},{"key":"2021113010212571900_B67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1874467210902030285","article-title":"Can colorectal cancer be prevented or treated by oral hormone replacement therapy?","volume":"2","author":"Li","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"2021113010212571900_B68","first-page":"5151","article-title":"Uroguanylin treatment suppresses polyp formation in the ApcMin\/+mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP","volume":"60","author":"Shailubhai","year":"2000","journal-title":"Cancer Res."},{"key":"2021113010212571900_B69","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1245\/s10434-006-9120-y","article-title":"The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis","volume":"13","author":"Iddings","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"2021113010212571900_B70","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2353\/jmoldx.2007.070032","article-title":"Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature","volume":"9","author":"Nicastri","year":"2007","journal-title":"J. Mol.Diagn."},{"key":"2021113010212571900_B71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3322\/canjclin.54.6.295","article-title":"The staging of colorectal cancer: 2004 and beyond","volume":"54","author":"Compton","year":"2004","journal-title":"CA Cancer J. Clin."},{"key":"2021113010212571900_B72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"2021113010212571900_B73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jama.2009.141","article-title":"Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer","volume":"301","author":"Waldman","year":"2009","journal-title":"JAMA, J.Am. Med. Assoc."},{"key":"2021113010212571900_B74","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-131-11-199912070-00002","article-title":"Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer","volume":"131","author":"Cagir","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"2021113010212571900_B75","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/bbrc.1996.0447","article-title":"Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency preparation of antisera","volume":"220","author":"Nakazato","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010212571900_B76","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1172\/JCI57925","article-title":"A uroguanylin-GUCY2C endocrine axis regulates feeding in mice","volume":"121","author":"Valentino","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021113010212571900_B77","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1152\/ajpendo.1978.235.3.E311","article-title":"Effect of toxigenic Escherichia coli on myoelectric activity of small intestine","volume":"235","author":"Burns","year":"1978","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010212571900_B78","doi-asserted-by":"crossref","first-page":"G725","DOI":"10.1152\/ajpgi.1989.257.5.G725","article-title":"Altered intestinal motility precedes diarrhea during Escherichia coli enteric infection","volume":"257","author":"Sjogren","year":"1989","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113010212571900_B79","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2010.09.019","article-title":"Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit","volume":"649","author":"Busby","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"2021113010212571900_B80","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","article-title":"Effect of 5\u00a0days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome","volume":"133","author":"Andresen","year":"2007","journal-title":"Gastroenterology"},{"key":"2021113010212571900_B81","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2009.12.050","article-title":"Efficacy of linaclotide for patients with chronic constipation","volume":"138","author":"Lembo","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/123\/12\/659\/442996\/cs1230659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/123\/12\/659\/442996\/cs1230659.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T05:45:21Z","timestamp":1638251121000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/123\/12\/659\/68981\/The-uroguanylin-system-and-human-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20120021","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]}}}